A 28-year-old woman with a history of two spontaneous second-trimester miscarriages presents with a 6 cm DVT in the left popliteal vein. Activated partial thromboplastin time (aPTT) is prolonged and does not correct with 1:1 mixing study. Anticardiolipin antibodies and anti-β2-glycoprotein-I antibodies are positive. What is the most appropriate immediate next step in management?

Explanation

## Clinical Diagnosis This patient has **Antiphospholipid Syndrome (APS)** with thrombosis and obstetric manifestations (recurrent miscarriages). The prolonged aPTT that does NOT correct on mixing study (in vivo inhibitor) and positive anticardiolipin/anti-β2GP-I antibodies confirm the diagnosis. ### Antiphospholipid Syndrome Classification | Feature | Finding | Significance | |---------|---------|---------------| | Thrombotic event | DVT present | Meets criteria | | Obstetric manifestation | 2 second-trimester losses | Meets criteria | | Serologic markers | Anticardiolipin + anti-β2GP-I | Meets criteria | | **Diagnosis** | **Definite APS** | **High-risk thrombophilia** | ## Management Algorithm for APS with Thrombosis ```mermaid flowchart TD A[APS with acute thrombosis]:::outcome --> B[Acute anticoagulation]:::action B --> C[UFH or LMWH]:::action C --> D{High-risk APS?}:::decision D -->|Yes<br/>Triple-positive or thrombosis| E[Warfarin INR 3-4]:::action D -->|No<br/>Single-positive| F[Warfarin INR 2-3]:::action E --> G[Long-term anticoagulation]:::action F --> G ``` ## Key Point: **High-risk APS (triple-positive: lupus anticoagulant + anticardiolipin + anti-β2GP-I) with thrombosis requires higher-intensity anticoagulation: warfarin INR 3–4, NOT 2–3.** Standard INR 2–3 is insufficient and associated with recurrent thrombosis. ## High-Yield Facts: - **Lupus anticoagulant** (prolonged aPTT not correcting on mixing) is the most thrombogenic marker in APS. - **Triple-positive APS** (all three serologic markers present) is considered "high-risk" and requires INR 3–4. - **Warfarin monotherapy is contraindicated as initial therapy** — must bridge with heparin to avoid warfarin-induced skin necrosis (protein C depletion). - **Pregnancy in APS** requires LMWH + low-dose aspirin (not warfarin due to teratogenicity). ## Clinical Pearl: APS is a **prothrombotic state masquerading as a coagulopathy** — the prolonged aPTT reflects an in vivo inhibitor (lupus anticoagulant), not a factor deficiency. Mixing study fails to correct because the inhibitor persists in the mixture. This patient is at extremely high risk for recurrent thrombosis and requires aggressive anticoagulation.